USPH Quote, Financials, Valuation and Earnings

Encompass Health has a net margin of 4.12% compared to US Physical Therapy's net margin of 8.61%. US Physical Therapy's return on equity of 3.86% beat Encompass Health's return on equity of 17.79%.

US Physical Therapy has a consensus price target of $108.33, signalling upside risk potential of 59.62%. On the other hand Encompass Health has an analysts' consensus of $117.18 which suggests that it could grow by 18.37%. Given that US Physical Therapy has higher upside potential than Encompass Health, analysts believe US Physical Therapy is more attractive than Encompass Health.

US Physical Therapy has a beta of 1.376, which suggesting that the stock is 37.634% more volatile than S&P 500. In comparison Encompass Health has a beta of 0.882, suggesting its less volatile than the S&P 500 by 11.77%.

US Physical Therapy has a quarterly dividend of $0.45 per share corresponding to a yield of 2.61%. Encompass Health offers a yield of 0.67% to investors and pays a quarterly dividend of $0.17 per share. US Physical Therapy pays 100.3% of its earnings as a dividend. Encompass Health pays out 13.78% of its earnings as a dividend. Encompass Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but US Physical Therapy's is not.

US Physical Therapy quarterly revenues are $180.4M, which are smaller than Encompass Health quarterly revenues of $1.4B. US Physical Therapy's net income of $7.4M is lower than Encompass Health's net income of $120.9M. Notably, US Physical Therapy's price-to-earnings ratio is 36.89x while Encompass Health's PE ratio is 22.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for US Physical Therapy is 1.52x versus 1.88x for Encompass Health. Usually stocks with elevated PS ratios are considered overvalued.

Kindly MD has a net margin of 4.12% compared to US Physical Therapy's net margin of -156.54%. US Physical Therapy's return on equity of 3.86% beat Kindly MD's return on equity of -201.03%.

US Physical Therapy has a consensus price target of $108.33, signalling upside risk potential of 59.62%. On the other hand Kindly MD has an analysts' consensus of -- which suggests that it could fall by --. Given that US Physical Therapy has higher upside potential than Kindly MD, analysts believe US Physical Therapy is more attractive than Kindly MD.

US Physical Therapy has a beta of 1.376, which suggesting that the stock is 37.634% more volatile than S&P 500. In comparison Kindly MD has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

US Physical Therapy has a quarterly dividend of $0.45 per share corresponding to a yield of 2.61%. Kindly MD offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. US Physical Therapy pays 100.3% of its earnings as a dividend. Kindly MD pays out -- of its earnings as a dividend.

US Physical Therapy quarterly revenues are $180.4M, which are larger than Kindly MD quarterly revenues of $647.9K. US Physical Therapy's net income of $7.4M is higher than Kindly MD's net income of -$1M. Notably, US Physical Therapy's price-to-earnings ratio is 36.89x while Kindly MD's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for US Physical Therapy is 1.52x versus 3.47x for Kindly MD. Usually stocks with elevated PS ratios are considered overvalued.

Pediatrix Medical Group has a net margin of 4.12% compared to US Physical Therapy's net margin of 6.07%. US Physical Therapy's return on equity of 3.86% beat Pediatrix Medical Group's return on equity of -12.67%.

US Physical Therapy has a consensus price target of $108.33, signalling upside risk potential of 59.62%. On the other hand Pediatrix Medical Group has an analysts' consensus of $18.07 which suggests that it could grow by 48.86%. Given that US Physical Therapy has higher upside potential than Pediatrix Medical Group, analysts believe US Physical Therapy is more attractive than Pediatrix Medical Group.

US Physical Therapy has a beta of 1.376, which suggesting that the stock is 37.634% more volatile than S&P 500. In comparison Pediatrix Medical Group has a beta of 1.325, suggesting its more volatile than the S&P 500 by 32.466%.

US Physical Therapy has a quarterly dividend of $0.45 per share corresponding to a yield of 2.61%. Pediatrix Medical Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. US Physical Therapy pays 100.3% of its earnings as a dividend. Pediatrix Medical Group pays out -- of its earnings as a dividend.

US Physical Therapy quarterly revenues are $180.4M, which are smaller than Pediatrix Medical Group quarterly revenues of $502.4M. US Physical Therapy's net income of $7.4M is lower than Pediatrix Medical Group's net income of $30.5M. Notably, US Physical Therapy's price-to-earnings ratio is 36.89x while Pediatrix Medical Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for US Physical Therapy is 1.52x versus 0.50x for Pediatrix Medical Group. Usually stocks with elevated PS ratios are considered overvalued.

The Oncology Institute has a net margin of 4.12% compared to US Physical Therapy's net margin of -13.15%. US Physical Therapy's return on equity of 3.86% beat The Oncology Institute's return on equity of -220.55%.

US Physical Therapy has a consensus price target of $108.33, signalling upside risk potential of 59.62%. On the other hand The Oncology Institute has an analysts' consensus of -- which suggests that it could fall by -26.2%. Given that US Physical Therapy has higher upside potential than The Oncology Institute, analysts believe US Physical Therapy is more attractive than The Oncology Institute.

US Physical Therapy has a beta of 1.376, which suggesting that the stock is 37.634% more volatile than S&P 500. In comparison The Oncology Institute has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

US Physical Therapy has a quarterly dividend of $0.45 per share corresponding to a yield of 2.61%. The Oncology Institute offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. US Physical Therapy pays 100.3% of its earnings as a dividend. The Oncology Institute pays out -- of its earnings as a dividend.

US Physical Therapy quarterly revenues are $180.4M, which are larger than The Oncology Institute quarterly revenues of $100.3M. US Physical Therapy's net income of $7.4M is higher than The Oncology Institute's net income of -$13.2M. Notably, US Physical Therapy's price-to-earnings ratio is 36.89x while The Oncology Institute's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for US Physical Therapy is 1.52x versus 0.52x for The Oncology Institute. Usually stocks with elevated PS ratios are considered overvalued.